NT5E and neoplasm: Although previous study revealed that the dual immune checkpoint inhibitors contribute to the enhanced efficacy of anti‐tumor, the high rate of irAEs restricts their clinical applications.[13] Based on these findings, we developed a calcium phosphate biomineralized nanomedicine for the co‐delivery of aPD‐L1 and APCP (a specific CD73 inhibitor) (Scheme 1B).